HeartRecovery
@HeartRecovery
Followers
2,244
Following
208
Media
409
Statuses
574
Recovering Hearts. Saving Lives. The latest news in heart recovery.
National
Joined December 2008
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
宝塚記念
• 218496 Tweets
LINGORM TSOU FANMEET
• 199521 Tweets
Afghanistan
• 172741 Tweets
#BBEBxZeeNuNew
• 135048 Tweets
ブローザホーン
• 107481 Tweets
SURROUNDED BY LOVE
• 72343 Tweets
FILLED WITH LOVE AT MNL
• 67958 Tweets
ドウデュース
• 67750 Tweets
#ユーフォ3期
• 51287 Tweets
ソールオリエンス
• 47602 Tweets
श्यामा प्रसाद मुखर्जी
• 37639 Tweets
ディープボンド
• 36341 Tweets
#anime_eupho
• 32891 Tweets
ベラジオオペラ
• 26871 Tweets
菅原騎手
• 26775 Tweets
ジャスティンパレス
• 22911 Tweets
菅原明良
• 20905 Tweets
プラダリア
• 19933 Tweets
ローシャムパーク
• 17420 Tweets
G1初制覇
• 15136 Tweets
#アイプラ3周年生放送
• 15016 Tweets
ヘルナンデス
• 10661 Tweets
Abiomed's Clinical Care App provides key resources health care professionals can access pre- and post-procedure at the point of care from the cath lab, ICU, OR or while in transport to improve patient outcomes. Download the new Impella® App:
0
13
16
At
#ACC22
,
@NavinKapur4
spoke about the life-saving potential of algorithms to provide hemodynamic guidance.
Notes the importance of tailoring algorithms for AMICS and HF CS.
0
5
19
If you’re at
#ISHLT2022
today, be sure to stop by the Abiomed booth to learn how you can Stay a Beat Ahead with Impella 5.5.
@ISHLT
0
6
18
#CTO2023
attendees - Join Abiomed today for a CTO Plus Lunch Symposium and hear from expert faculty Kate Kearney, MD, Taishi Hirai, MD,
@KAlaswadMD
, and
@RajTayalMD
on OPTIMUM data and case based examples of Impella ECP and LP sheath.
0
3
17
If you’re at
#STS2023
, stop by the Abiomed booth to learn about new innovations with Impella 5.5 with SmartAssist, Impella RP Flex and more.
0
7
16
"This technology is really going to level the playing field for all operators." -
@DrAmirKaki
on breaking the small bore barrier.
#TCT2021
#CardioTwitter
0
5
16
Are you planning to take part in
#ELSO2022
next week? Join Abiomed's symposium - ECpella™ Therapy: Optimal Timing & Management to Rest & Recover with Impella®- with moderator Sanjeev Aggarwal, MD & expert speakers Roberto Lorusso, MD, Alan Gass, MD and Evgenij Potapov, MD.
0
2
15
Finishing day 2 of
#ACC22
strong,
@Babar_Basir
makes the case that "Door-to-Support" time matters most.
Key point: MCS is an initial therapy in AMI-CS - delay is associated with higher mortality, while a 7-15 min delay to provide pre-PCI support does not increase infarct size.
0
3
13
A good explanation of the inclusion criteria and endpoints for PROTECT IV from
@PaulMahoneyMD
at
#CRT2022
, along with a compelling presentation of case of a 60 yo male who was randomized to the Impella arm and successfully revascularized.
0
3
11
Watch
@Babar_Basir
discuss his paper titled “Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock" with
@DrSethdb
:
1
4
10
Happening this evening at
#THT2023
! "Navigating CAD in the Compromised Heart." with experts
@JJheart_doc
,
@dranulala
,
@RhianEDavies1
and David D’Alessandro, MD will discuss optimal revascularization strategies for patients with CAD.
0
2
10
Another interesting presentation at ACC.22.
@Babar_Basir
discussed the role of MCS in STEMI.
Some of the strongest data to date comes from the NCSI - which found that early placement of Impella as part of a shock protocol approach led to improved outcomes.
0
3
10
Fellows! Don't miss this Saturday's
@CRT_meeting
virtual Fellows Boot Camp -MECHANICAL SUPPORT FOR PCI | SHOCK - featuring a hands-on demonstration of Impella CP from
@HashimHayder
.
Register:
1
2
6
Another great presentation at
#CRT2022
as
@ColinHirstMD
gives a talk on his hospital's experience with the Impella ECP as part of the Innovation Hub session "Breaking the "Small Bore Barrier" in pMCS for High Risk PCI: Early Experience with the 9F IMPELLA ECP Device."
0
3
9
A successful Friday at the 2022 A-CURE symposium last week featuring educational talks from Bart Meyns, MD,
@NavinKapur4
,
@BillONeillMD
,
@BurkhoffMd
,
@Babar_Basir
, and an excellent keynote from
@BiykemB
.
1
3
9
Watch:
@Babar_Basir
discusses the journey from NCSI to RECOVER IV, including a brief overview of what following the NCSI protocol looks like:
0
2
9
If you're at
#CTO2023
this week, join us at Abiomed's CTO Plus Lunch Symposium - The Future in Data and Technology: The Rise of Heart Recovery.
0
0
9
Are you at
#ELSO2022
today? Join Abiomed's symposium - ECpella™ Therapy: Optimal Timing & Management to Rest & Recover with Impella®- with moderator Sanjeev Aggarwal, MD & expert speakers Roberto Lorusso, MD, Alan Gass, MD and Evgenij Potapov, MD.
0
3
9
A great (and quick!) breakdown of the DanGer Shock RCT.
1
6
22
0
4
8
#STS2023
attendees. Learn about the Impella 5.5® with SmartAssist® - delivering full cardiac support with maximum unloading, the Impella 5.5 allows the heart to rest and recover. Learn more:
0
3
7
Watch an informative discussion with
@MarioIannaccon8
&
@adityadoc1
at
#SCAI2022
on recent meta-analysis of timing of Impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock:
0
2
8
Tune in for a Thursday Night Live webinar, in collaboration with
@AATSHQ
- Low Cardiac Output Syndrome: Impacting Patient Outcomes Through A Heart Team Approach - October 26 at 8:00 PM EST.
Register:
1
2
7
"The proof is in the pudding. And this is the moment when I said wow this thing is the real deal. At 9 French we're getting almost 4 liters of output."
@DrAmirKaki
#TCT2021
0
4
8
A great discussion on ECpella versus ECMO in Cardiogenic Shock from
@MarioIannaccon8
and
@VPanoulas
. 👇
First part of the discussion with
@VPanoulas
. Improving evidences about
#cardiogenicshock
#ECPELLA
#ECMO
Thank to all the collegues that helped in the pubblication
@sal_colangelo
@BoccuzziGiacomo
@ovidio_def
@Fabri84Dascenzo
@agtruesdell
1
2
16
0
0
8
As part of a recent CAMP course designed to facilitate the sharing of best practices in AMI CGS & HRPCI,
@DrAmirKaki
emphasized the need to optimize care of patients with AMICS before leaving the cath lab. Watch the full talk here:
#FOAMed
0
3
8
Watch
@DrSethdb
's informative author discussion with
@CVandenbriele
on his paper - Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure.
0
4
8
If you're taking part in
#ISHLT2022
, be sure to stop by the Abiomed booth to learn more about innovative technologies like the Impella 5.5® with SmartAssist®:
0
0
8
"In Recover IV we plan to implement all of the best practices we've learned in the past few decades." -
@NavinKapur4
speaking on Door to Unload: Implications for STEMI, HR-PCI and Cardiogenic Shock at
#TCT2021
.
0
4
8
Next up at
#ACC22
,
@JHMontfort10
discusses Impella as the best short-term MCS strategy for CGS.
Advantages noted with Impella include:
- Allowance for for tailored therapy and a focus on well-being
- Versatility & rapid transitions, with uses in Uni/BiV, LV Vent, & Hybrid
0
1
8
If you're planning ahead for
#CTO2023
next week, add Abiomed's CTO Plus Lunch Symposium to your agenda. Expert faculty including Kate Kearney, MD, Taishi Hirai, MD,
@KAlaswadMD
, and
@RajTayalMD
will discuss OPTIMUM data and case based examples of Impella ECP and LP sheath.
0
3
7
#CTO2023
attendees - Did you know the emergence of Low Cardiac Output Syndrome significantly increases length of ICU and hospital stay, 30-day readmission rates, and costs of treatment? Learn about Impella 5.5's potential to help these patients:
0
1
7
The RECOVER IV Randomized Controlled Trial will assess whether Impella support, used pre-PCI, is superior to PCI without Impella in patients with AMI cardiogenic shock. Learn more about Abiomed's ongoing commitment to clinical research:
0
0
7
"If you enter the hospital as a SCAI B patient there is a 90% chance you will escalate to a later SCAI stage." -
@NavinKapur4
talking about why the Cardiogenic Shock Workgroup believes "B is for Bad."
0
0
7
Watch Alaide Chieffo, MD, discuss an IMP-IT registry sex subanalysis with Bobbi Bogaev Chapman, MD:
#womenincardiology
#WIC
0
1
7
Another exciting session happening at
#ISHLT2022
now as Danny Ramzy, MD, discusses the Impella 5.5.
“The survival rates are a testament to using acute therapy early.”
0
0
7
Our stellar fellow
@BDH131
presenting a fascinating ‘save’ by our stellar team
#ACC2
@ACCinTouch
#ECMO
#Impella
#ACTAT
@sanjukapaganti
@SKumar_UTHealth
@JumeanMarwan
@IsmaelSalasMD
@HoustonShockHSS
@DinaSRamini
@UTHCardiology
0
1
17
1
1
7
Results of a new per-protocol analysis of the STEMI DTU pilot trial data presented at
#TCT2022
. Read more:
0
2
7
Despite pharmalogical support, 10.1% of adults undergoing cardiac surgery develop Low Cardiac Output Syndrome, which can increase the risk of mortality by 12 to 25-fold. Learn about Impella 5.5's potential to reduce the severity for these patients:
0
3
7
"I consider this technology a game changer...once you realize how easy this is to use, you find that you use it more and more." - Dave D’Alessandro, MD talks about the Impella 5.5® with SmartAssist® at
#ISHLT2022
0
0
7
Did you know? It's believed that in 1981, Alphonzo Jordan, MD, became the first African American doctor to perform percutaneous coronary angioplasty procedures on a regular basis.
#BlackHistoryMonth
0
3
5
Mark your calendars for Abiomed's Industry lunch-time symposium to hear real-world strategies to apply to optimize the heart recovery pathway for patients.
0
2
6
Cardiac and vascular surgeons can explore resources to improve outcomes for surgical patients in our education library at . Resources like OR and ICU Checklist Best Practices for Impella 5.5® with SmartAssist®. Learn more:
0
4
6
Are you taking part in
#STS2022
? Join
@Abiomed
's symposium - Staying A Beat Ahead: Impella 5.5 with SmartAssist for your Cardiogenic Shock Patients - with
@EdSolteszMD
, Elias A. Zias, MD, and David Kaczorowski, MD of
@UPMC_CTSurgery
. Register here:
0
2
6
0
1
6
Starting day 2 at
#ACC22
with a presentation on the trends in treatment of CGS from
@NavinKapur4
.
“The time to intervene is when patients are in the earlier stages of cardiogenic shock.”
0
3
6
Join Abiomed for its 2nd Annual Abiomed Innovation event at
#ISHLT2024
!
Hands-on demonstrations of Impella 5.5® with SmartAssist®, ECpella with Impella 5.5®, and the CAMP Education Platform.
Advanced registration is required:
0
2
6
#SCCM2023
attendees - did you know that with both a minimally invasive axillary approach and anterior direct insertion options, the Impella 5.5® with SmartAssist® offers the versatility needed for dynamic patient management? Learn more:
0
0
6
Don't miss
@BillONeillMD
's presentation - Real World Evidence Leading to RECOVER IV - at
#TCT2021
next week as part of
@Abiomed
's Satellite Symposium: Clinical Science to Landmark Trials of LV Unloading in High-Risk PCI and Cardiogenic Shock. Learn more:
0
5
6
Happy
#NPWeek
! We're sharing some of our educational resources to help NPs care for their Impella patients:
0
0
6
An informative poster from
@nbrozzimd
at
#ISHLT2022
finds “Impella 5.5 provided robust hemodynamic support for patients with severe cardiogenic shock, with over 50% hospital survival, including a third of patients bridged to heart transplant.”
0
1
6
Another informative presentation at
#CRT2022
with an overview of the Impella ECP from
@duanepinto
.
0
1
6
What would you do? Angiography reveals occluded RCA, left circumflex disease, and LAD disease. This interesting case - with a lot of questions and decision-making along the way - is presented by
@NavinKapur4
. Check it out here:
1
4
5
DanGer Shock, an independent investigator-initiated study, is the first RCT of Impella in cardiogenic shock to complete enrollment. Learn more:
0
1
6
In case you missed it: Watch an informative discussion with
@MarioIannaccon8
&
@adityadoc1
at
#SCAI2022
on recent meta-analysis of timing of Impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock:
0
1
5
#AATS24
attendees - Join Abiomed for an evening industry discussion to hear real-world strategies for optimizing the heart recovery pathway for patients.
Register here:
0
1
6
Watch a replay of a Coronary Artery & Myocardial Protection webinar from earlier this year in which a panel of physicians discussed the planning, timing, and management of Impella® with VA ECMO (ECpella):
0
1
5
Are you planning for
#HFSA2022
?
Don't miss Abiomed's Industry Expert Theater - Turning the Tide of Heart Failure: Who will rise to the challenge?
0
2
6
Early identification of patients with AMICS allows for early use of mechanical circulatory support.
Learn about this and other key best practices from the NCSI study from Babar Basir, DO's recent discussion:
0
1
4
Some interesting insights on antithrombotic management in the below publication.
For anyone interested, you can also find information on optimizing anticoagulation for patients receiving Impella support from
@beaverspharmd
Et al. here:
🆕 📑
#antithrombotic
tx for
#Impella
#VAD
🩸risk: <65 years, 💔⚡️, peripheral insertion, on
#DAPT
,
#IABP
or
#antiXa
> 0.4IU/mLx2 🤔
✅ it out🫀
@OliviaIskaros
@ArnoukSerena
@AltshulerDiana
@JPCritCarePharm
@ColombianpharmD
@nyulangone
⤵️
1
7
21
0
0
5
Must watch: Junya Ako, MD presents results of his new Japanese Registry for Percutaneous Ventricular Assist Devices (J-PVAD) study during
#TCT2022
.
0
2
5
Join us at SCAI for a Scientific Sessions symposia focused on the latest advancements in cardiac care, highlighting Impella Therapy and improving patient outcomes.
0
1
5
If you're at
#AATS24
- there's still time to register for Abiomed's AATS dinner symposium - Navigating High-Risk Surgical Procedures Using Impella 5.5® with Smartassist® To Optimize Outcomes:
0
1
5
Are you going to
#THT2024
? Join Abiomed for a symposium exploring strategies to optimize the timing of Impella initiation, providing more time for assessment and long-term treatment planning.
0
1
5
Join us this Thursday (11/9) for Thursday Night Live - Innovation in the ICU: APP Driven Impella® Management and Repositioning - highlighting the implementation of a novel process to meet the needs of critical care patients requiring temporary MCS.
0
2
5
Bicarbonate-Based Purge Solution During Impella Support: A Growing Alternative.
Learn more:
0
3
5
Timely treatment using a best practice protocol, including early use of MCS, hemodynamic monitoring, and aggressive reduction of inotropes and pressors, can help patients achieve myocardial recovery. Find more on AMICS patient identification here:
0
1
5
At
#TCT2022
@VPanoulas
with an interesting presentation on the use of a protocolized approach and a dedicated shock-team. Study suggests that this leads to significant reductions in 30-day mortality in acute coronary syndrome patients with cardiogenic shock.
0
1
5
If you're at the Houston Shock Symposium this weekend join Abiomed for a Impella Repositioning & Troubleshooting Workshop! In this session, clinicians will learn strategies for utilizing echo to optimize Impella placement, as well as Impella alarm management.
#HSS24
0
2
5
Tune in later today for an interactive webinar focusing on best practices related to developing a cohesive heart team and patient management, and outcomes this approach has produced, from
@afzal_aasim
and Tim George, MD.
0
1
5
Are you going to
#THT2024
? Join Abiomed for a symposium exploring strategies to optimize the timing of Impella initiation, providing more time for assessment and long-term treatment planning.
0
2
5
Cardiology Fellows - would you like to improve your technical skills for large bore access & closure? Take part in
@Abiomed
's Large Bore Access Closure Program at
@crfheart
#Fellows2023
with
@JWMoses
, Siddharth WayangankarMD,
@DrAnkitKPatel
&
@kjkunkelmd
.
0
3
5
Did you know? Advancements in Impella technology and best practices have further improved AMICS patient outcomes since the DanGer Shock RCT began enrolling in 2013.
0
2
5
#AATS24
attendees - Join Abiomed for an evening industry discussion to hear real-world strategies for optimizing the heart recovery pathway for patients.
Register here:
0
1
5
Watch an educational discussion between
@NatalieTapaskar
and
@AkiItohMD
about his study of the Impella 5.5® with SmartAssist® presented at
#ISHLT2022
.
@CardioNerds
Want to learn more about the use of Impella 5.5 in clinical practice? Check out this interview with expert Dr. Akinobu Itoh from
@BrighamWomens
. Thanks
@mydocwire
and
@CardioNerds
for the opportunity!
0
2
17
0
3
5
Changing the Impella access site dressing in the ICU is similar to any other sterile dressing change. Get more key tips here:
0
0
5
Interesting case. 👇 Thanks for sharing
@JosiahBrownMD
.
Final IVUS of ramus-LM -> post-dil w/ 3.0 NC
Final angios. Not bad!
Impella weaned and removed at end of case, just on a bit of dobutamine.
Extubated POD 2, discharged home HD 10. EF 25 -> 40%.
Outpt TAVR coming up!
1
0
3
0
1
5
Are you taking part in
#TCT2021
this year? Visit our dedicated TCT page: for all the coverage you need in one place!
0
3
5
An interesting case study illustrating the importance of being prepared for post-cardiotomy cardiogenic shock (PCCS) in patients with comorbidities.
0
0
5
If you're making your plans for
#NTI2023
, don't miss
@Abiomed
's Sunrise Session "Putting the “I” Back in Team: Care of the Impella Patient in the ICU" with
@eddyjoemd
, MD & Linda Suplicki RN, MSN, ACNP, CCRN.
Tuesday, May 23 at 7:00 AM.
Register:
0
0
5
New Impella 5.5 data from
#ISHLT2022
! Danny Ramzy, MD, presented improved clinical outcomes with Impella 5.5 compared to Impella 5.0 in cardiogenic shock and heart failure patients.
0
2
5
Read an interesting case report on the successful use of Impella 5.5 to manage cardiogenic shock complicated by COVID-19:
0
4
5
Bicarbonate-Based Purge Solution During Impella Support: A Growing Alternative.
Learn more:
0
0
5
Don't miss Abiomed's live webinar this Thursday (4/27)!
"Putting The "I" back in Team-Impella Management in the ICU" with
@eddyjoemd
& Viktoriya Kagagn, APN.
This program has been approved by the AACN for 1.0 CERPs.
Register:
0
1
5
Attending
#ASAIO2022
this year? Be sure to add
@Abiomed
's Lunch Symposium - Give It A Rest: How the Use of Impella + VA ECMO (ECpella) Allows Your Patient’s LV to Rest and Recover - to your agenda.
Sign up here:
0
1
5
Don't miss the case-based discussion on early identification and institution of MCS and Impella 5.5® with SmartAssist® by speakers Lauren Barron, MD, Edward Soltesz, MD, Scott Silvestry, MD, & Marc Moon, MD at the 103rd
@AATSHQ
meeting.
0
0
5
Interesting
#ACC22
abstract: compared to ECMO alone, initiation of EC-Pella before reperfusion reduces LV PVA, activates cardioprotective signaling, & reduces infarct size. These findings suggest that LV unloading may mitigate LV injury due to ECMO in AMI.
0
2
5
Dave D’Alessandro, MD mentions ability to position the pump is much more exact with the Impella 5.5 which means hemolysis is unlikely.
#ISHLT2022
1
0
5
First up at
#TCT2021
-
@GreggWStone
discusses the PROTECT series, noting that MCS can allow for more time for complete revascularization, which is associated with improved outcomes.
0
4
5
Today at 3:00 p.m. EST!
Join Abiomed's live webinar in cooperation with
@CardioBusiness
and learn about improving patient outcomes through stronger heart teams with expert
@AAHilliardMD
!
Register:
0
1
5
Speaking at
#STS2023
@EvgenijVPotapov
presents an algorithm for severe CGS treatment with tMCS.
0
2
5
Case Review: Ultra-Low Contrast PCI of LM-LAD with LV Mechanical Circulatory Support - from
@ziadalinyc
at
#CRT2021
.
0
1
5
“If ECMO is an airbag, I believe the Impella 5.5 can act as a break to avoid getting to ECMO” - Dave D’Alessandro, MD with a great metaphor to end this informative session at
#ISHLT2022
0
1
5
Interesting case! ⬇
65M ESRD, HFrEF with EF 15-20% presented to outside facility for Nstemi an aoc CHF. Diffusely diseased vessels, not a CABG candidate. Impella mcs, orbital, prox to mid lad first for outflow, then TAP ostial circ and left main into LAD.
0
0
1
0
0
5
At
#TCT2022
Adam Salisbury, MD, presented preliminary results of the OPTIMUM study - Examining the association between prophylactic use of Impella (“Protected PCI”) and clinical outcomes. Watch the presentation here:
0
2
5